ClinicalTrials.gg
Not yet recruitingNCT07052526Updated Jul 9, 2025

Comparative Evaluation of Hydrophilic and Hydrophobic Sealants in Partially Erupted First Molars

An interventional study of Prevention and Prevention of caries in Dental Caries, sponsored by Mansoura University. Not yet recruiting at 1 site in Egypt. Open to participants aged 5 Years to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-09.

Sponsored by Mansoura University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
5 Years to 7 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Dental Caries by Mansoura University — 5 open to participants now, 12 under way, none of them phase 3. Dental Caries · Mansoura University.

Planned enrollment
Largest of 19
150 · median 40
Started
2025
with 5 others
No phase
19 of 19
5 open now
Primary completion
2027-01
later than 7 of 11 live
Registered
11th of 19
by date

Among the 19 studies in Dental Caries by Mansoura University, this one has the largest planned enrollment, is one of 6 that started in 2025, is one of 19 with no phase, reaches primary completion later than 7 of the 11 other live ones, and was the 11th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

5 of the 19 studies in Dental Caries by Mansoura University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 5 Years to 7 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Dental Caries by Mansoura University, or all of them as a file.
02

Study summary

This randomized controlled clinical trial aims to evaluate and compare the retention, caries prevention, microleakage, and fluoride release of three types of pit and fissure sealants-hydrophilic, nanofilled hydrophobic, and conventional hydrophobic-applied to partially erupted first permanent molars in children aged 5 to 7 years. The study uses a split-mouth design and includes both clinical and laboratory evaluations over an 18-month period. Outcomes will assess sealant effectiveness with and without the use of a bonding agent.

Read the detailed description

This is a randomized controlled clinical trial designed to evaluate and compare the effectiveness of three types of pit and fissure sealants-hydrophilic (Embrace WetBond), nanofilled hydrophobic (DENU Seal), and conventional hydrophobic (Helioseal F)-when applied to partially erupted first permanent molars in children aged 5 to 7 years. The study aims to assess the sealants' clinical retention, their ability to prevent dental caries, microleakage, sealant penetration depth, and fluoride release.

A total of 150 children will be randomly assigned to three equal groups of 50 participants each. A split-mouth design will be used: in each group, sealants will be applied with and without bonding agents on opposite sides of the upper or lower arch, allowing intra-subject comparisons. Clinical evaluations will be conducted at 3, 6, 12, and 18 months to assess sealant retention and caries incidence using the modified Color, Coverage, Caries (CCC) Sealant Evaluation System.

In addition to the clinical phase, a laboratory phase will be conducted using extracted human premolars. This phase will evaluate microleakage and sealant penetration under a stereomicroscope following dye penetration techniques. Fluoride release will be measured at specified time intervals (1, 7, 14, 21, and 28 days) using an ion-selective electrode in artificial saliva conditions maintained at 37°C.

The primary outcomes include sealant retention and caries incidence. Secondary outcomes focus on the degree of microleakage, sealant penetration, and fluoride release. The trial will help determine whether moisture-tolerant sealants offer superior clinical and preventive benefits over traditional hydrophobic materials, particularly in situations where ideal isolation is difficult, such as with partially erupted teeth in young children.

The study will be conducted at the Pediatric Dentistry Clinic, Faculty of Dentistry, Mansoura University, and is expected to generate evidence that could improve clinical decision-making in preventive pediatric dentistry.

03

Conditions studied

  • Dental Caries

Browse trials for

Keywords

  • Hydrophilic sealant;
  • Fluoride
  • Microleakage
  • Caries
  • Retention
04

Who can participate

Ages eligible
5 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

-

Inclusion criteria

Inclusion Criteria:

  • Cooperative children (Frankl Scale 3)
  • good oral hygiene (OHI-S Index),
  • 2 partially erupted 1st molars

Exclusion criteria

Exclusion Criteria:

  • Cavitated caries
  • fluorosis
  • hypoplasia
  • restored teeth
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Helioseal Fplus

    Participants in this arm will receive the Helioseal F Plus resin-based sealant, applied to occlusal surfaces of permanent molars. The sealant will be applied according to the manufacturer's

    Other: Prevention

  • Experimental
    1 - Hydrophilic Sealant (Embrace WetBond)

    Participants will receive Embrace WetBond sealant, a moisture-tolerant resin sealant applied to slightly moist occlusal surfaces. The sealant is light-cured for 20 seconds

    Other: Prevention of caries

  • Experimental
    Denu seal

    Participants in this arm will receive Denuseal, a fluoride-releasing sealant, applied to occlusal surfaces of permanent molars under dry conditions. The sealant will be light-cured for 20 seconds.

    Other: Prevention therapy

Interventions

  • OtherPrevention

    Conventional Hydrophobic Sealant (Helioseal F - Control) will be used as a positive control; applied to partially erupted molars with and without bonding in a split-mouth design.

    Also known as: Helioseal-F plus

  • OtherPrevention of caries

    Embrace WetBond sealant will be applied to partially erupted first permanent molars using a split-mouth design with and without bonding agent.

    Also known as: Hydrophilic Embrace-Wetbond

  • OtherPrevention therapy

    DENU Seal applied using a split-mouth design to evaluate bonding and non-bonding application outcomes from retention and caries prevention

    Also known as: Denuseal

06

What researchers measure

Primary outcomes

  1. Retention

    retention is evaluated using CCC Index (Color, Coverage, and Caries) This scale is used to assess sealant retention and caries status during follow-up evaluations. Score Description Retention Caries Status Interpretation 0 Sealant completely retained no caries Full retention Best outcome 1. Partial sealant loss no caries Partial loss Acceptable 2. Sealant completely lost no caries Total loss Less ideal 3. Sealant partially or totally lost caries present Partial or total loss Worst outcome

    Time frame: 18 months

  2. Caries

    Caries Incidence: 3, 6, 12, 18 months, t each recall (3, 6, 12 months), evaluate each sealed tooth using the CCC score: If the sealant is completely intact and no caries is visible → score = 0 If the sealant is partially gone but no decay → score = 1 If sealant is lost but still no decay → score = 2 If sealant is lost/partial and there is decay → score = 3

    Time frame: 18 months

Secondary outcomes

  1. Microleakage

    Microleakage Assessment (lab) - dye penetration . Score Description Microleakage Depth Interpretation 0 No dye penetration 0% of fissure depth Best outcome 1. Dye penetrates into enamel only \<50% of enamel Good 2. Dye penetrates to dentino-enamel junction (DEJ) Reaches DEJ, no dentin Borderline 3. Dye penetrates into dentin Past DEJ into dentin Worst outcome Minimum score: 0 = no leakage Maximum score: 3 = extensive leakage Higher score = worse outcome

    Time frame: 3 months

  2. Fluoride release

    Fluoride Release - spectrophotometer (1, 7, 14, 21, 28 days) Fluoride Release Scoring System (Modified Scale for Clinical Correlation) Because fluoride release is continuous and measured in ppm or µg/cm²/day, we can categorize release levels into scores for easier interpretation. Score Fluoride Release Level Typical Range Interpretation 0 High, sustained release \>2 ppm after 1 week Best outcome 1. Moderate release 1-2 ppm after 1 week Good 2. Low release 0.5-1 ppm after 1 week Weak effect 3. Negligible release \<0.5 ppm after 1 week Ineffective

    Time frame: 2months

07

Study locations

1 site
  • Facility of Dentistry،Mansoura University
    Al Mansurah, Egypt
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2025; primary completion for Jan 2027, 18 months later.

Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 18 months is above that.

Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 26, 2025
First posted
Jul 4, 2025
StartEst.
Jul 1, 2025
Primary completionEst.
Jan 1, 2027
CompletionEst.
Apr 1, 2027
Last update
Jul 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07052526
Responsible party
Heba Mohamed (Assisstant lecturer, Mansoura University) — Principal investigator
First posted
Jul 4, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Jul 9, 2025

Study contacts

Dr. Heba Mohamed DEGHID, Master
Contact
Heba.pl70@gmail.com
2001016684174
Dr rabaa MAHMOUD ABOU Bakr, Professor
principal investigator · Mansoura University - Pediatric Dentistry Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion